✦ LIBER ✦

Possible Explanation for Loss of Detectable Antibody in Patients with Disseminated Malignant Melanoma

✍ Scribed by LEWIS, M. G.; PHILLIPS, T. M.; COOK, K. B.; BLAKE, J.

Book ID: 109678313
Publisher: Nature Publishing Group
Year: 1971
Tongue: English
Weight: 378 KB
Volume: 232
Category: Article
ISSN: 0028-0836
DOI: 10.1038/232052a0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of high-dose tamoxifen (N

Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma

✍ Edward T. Creagan; James N. Ingle; David L. Ahmann; Stephanie J. Green 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 3 views

Seventeen patients with disseminated malignant melanoma received a daily oral regimen of tamoxifen, 100 mg/m2. All patients had prior chemotherapy and predominantly visceral involvement. None of the patients had an objective regression and most (71%) had progressive disease at the time of first reas

Evaluation of interferon alpha-2B and th

Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026

✍ Laura F. Hutchins; James Moon; Joseph I. Clark; John A. Thompson; Marianne K. La 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 1 views

## Abstract ## BACKGROUND. Southwest Oncology Group protocol 0026 evaluated interferon alpha‐2b plus thalidomide in patients with disseminated melanoma. Endpoints were 6‐month progression‐free survival rate, response rate, and toxicity. ## METHODS. Twenty‐six patients with Stage IV melanoma, mea

Immunoscintigraphy with99mTc labelled F(

Immunoscintigraphy with99mTc labelled F(ab′)2fragments of an anti melanoma monoclonal antibody (225.28S) in patients with metastatic malignant melanoma

✍ Thomas Cerny; Susan E. Owens; Shirley A. Mackenzie; Pamela M. Nuttall; Anna K. G 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 438 KB

Immunoscintigraphy and Pharmacokinetics

Immunoscintigraphy and Pharmacokinetics of Indium-111-labeled ZME-018 Monoclonal Antibody in Patients with Malignant Melanoma

✍ Koizumi, Mitsuru ;Endo, Keigo ;Watanabe, Yuji ;Saga, Tsuneo ;Sakahara, Harumi ;K 📂 Article 📅 1988 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 640 KB

Reasons for delay in primary treatment o

Reasons for delay in primary treatment of British patients with malignant melanoma

✍ Valerie Doherty; J. Ashworth; J. English; Rona Mackie 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Elevated plasma levels of transforming g

Elevated plasma levels of transforming growth factor (TGF)-β1 and TGF-β2 in patients with disseminated malignant melanoma

✍ Krasagakis, K; Thölke, D; Farthmann, B; Eberle, J; Mansmann, U; Orfanos, CE 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 474 KB